MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    The Efficacy of a Remote Cognitive Remediation Therapy (CRT) Program on Parkinson’s Disease

    N. Piniella, N. Burt, S. Yasin, N. Volino, M. Baker, M. Jung, A. Leder, A. Sousa, L. Hoffman (Glen Head, USA)

    Objective: To determine the feasibility and impact of remote cognitive remediation therapy (CRT) on cognitive function and quality of life (QOL) in patients with Parkinson’s…
  • 2022 International Congress

    Feasibility and acceptability of PDConnect: a collaborative approach to physical activity for people with Parkinson’s.

    J. Jones, L. Alexander, L. Hancock, K. Cooper (Aberdeen, United Kingdom)

    Objective: To evaluate the feasibility and acceptability of a novel collaborative telehealth based physical activity intervention for people with Parkinson’s. Background: The benefits of physical…
  • 2022 International Congress

    Resequencing of the complete SNCA locus in Indian patients with Parkinson’s disease

    A. Kishore, M. Sturm, S. Krishnan, G. Sarma, C. Hakkaart, A. Sreelatha (Kochi, India)

    Objective: To perform targeted resequencing of the SNCA locus to identify novel variants in the Indian patients with Parkinsons’s disease (PD). Background: To date, most…
  • 2022 International Congress

    Deep learning applied to retinal OCT images to differentiate Parkinson’s disease patients from healthy controls

    M. Barrenechea, D. Romero-Bascones, A. Murueta-Goyena, JC. Gomez-Esteban, A. Alberdi, A. Erramuzpe, U. Ayala, I. Gabilondo (Mondragon, Spain)

    Objective: This study aims to investigate the capability of artificial intelligence, more precisely deep convolutional neural networks (CNN), to automatically classify between healthy controls (HC)…
  • 2022 International Congress

    The Complexity of Parkinson Disease Medication Regimens May Factor into Treatment Decisions: Results of a PMD Alliance Survey

    J. Farmer, C. Goas, J. Rivera, A. Mitchell, A. Merriam, N. Crouse, A. Formella (Pennington, USA)

    Objective: Identify factors affecting PwPD and CP communications with HCPs regarding dyskinesia and OFF episodes. Background: Managing Parkinson Disease (PD) requires clear and open communication…
  • 2022 International Congress

    Tullio phenomenon in CANVAS Syndrome

    T. Liu, N. Badihian, L. Jackson, A. Hassan, E. Coon (Rochester, USA)

    Objective: To describe Tullio phenomenon in a patient with CANVAS (cerebellar ataxia with neuropathy and vestibular areflexia syndrome). Background: CANVAS is a progressive ataxia syndrome…
  • 2022 International Congress

    Evaluation of rapid eye movement behavioral disorder (RBD) in sporadic adult onset ataxia (SAOA)- A prospective observational study

    ANI. Das, A. Srivastava, A. Jaryal, R. Rajan (Delhi, India)

    Objective: 1. To evaluate the presence of RBD in patients with SAOA2. To follow up patients of SAOA with RBD whether they develop multiple system…
  • 2022 International Congress

    Benefit of multiple incobotulinumtoxinA injections for pain reduction in adult patients with limb spasticity: an analysis of pooled data from phase 2 and 3 studies

    J. Wissel, A. Camões-Barbosa2, G. Comes, M. Althaus, A. Scheschonka, D. Simpson (Potsdam, Germany)

    Objective: To assess pain relief after multiple incoA injections in a large sample of pts with limb spasticity-associated pain (SAP) using pooled data from six…
  • 2022 International Congress

    The agreement between automated and expert FOG annotations during an at-home protocol: influence of dopaminergic medication and task

    N. D'Cruz, D. Zoetewei, T. Herman, P. Ginis, J. Hausdorff, A. Nieuwboer (Leuven, Belgium)

    Objective: To investigate agreement between a recent automated FOG detection algorithm and expert video ratings, and the influence of dopaminergic medication and task context. Background:…
  • 2022 International Congress

    Genetics Of Parkinson’s in India – Young Onset Parkinson’s Disease (GOPI-YOPD) : Genetics of Juvenile, Young and Early Onset Parkinson’s Disease

    P. Kukkle, V. Goyal, T. Geetha, R. Menon, R. Kandadai, U. Mahadevia, H. Kumar, R. Borgohain, A. Mukherjee, P. Wadia, R. Yadav, S. Desai, N. Kumar, S. Nair, S. Murugan, A. Biswas, P. Pal, M. Oliver, S. Sundaram, M. Deshmukh, A. Bassi, C. Sandeep, N. Mandloi, A. Kayalvizhi, U. Muthane, S. Das, S. Seshagiri, R. Gupta, V. Ramprasad (Bangalore, India)

    Objective: To determine the genetic and demographic patterns of juvenile-onset (JOPD, <20 years), young-onset (YOPD, 20-40 years), and early onset (EOPD, 40-50 years) Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley